Mirae
Operates a healthcare service focused on expanding patient access to world-class specialty care, backed by launch funding.
Overview
Mirae is a healthcare company launching to expand access to world-class specialty care. The company targets patients and healthcare stakeholders seeking easier access to high-quality specialist expertise, with the available disclosure positioning specialty-care access as its core focus. The company announced launch funding of about $5.4 million, while the provided funding summary lists $5 million raised across one undisclosed round dated July 28, 2026. No specific AI capabilities, product architecture, customers, investors, or headquarters were disclosed in the provided context.
Funding History
Mirae Launches With $5.4M in Funding to Expand Access to World-Class Specialty Care
Frequently Asked Questions
- How much funding does AI Funding track for Mirae?
- AI Funding tracks $5M for Mirae across 1 funding round in this database.
- What does Mirae do?
- Mirae is a healthcare company launching to expand access to world-class specialty care. The company targets patients and healthcare stakeholders seeking easier access to high-quality specialist expertise, with the available disclosure positioning specialty-care access as its core focus. The company announced launch funding of about $5.4 million, while the provided funding summary lists $5 million raised across one undisclosed round dated July 28, 2026. No specific AI capabilities, product architecture, customers, investors, or headquarters were disclosed in the provided context.
- Where is Mirae headquartered?
- Mirae is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.